List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 22 studies with search of: Temozolomide AND melanoma | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
Conditions: Skin Cancer;   Melanoma;   Metastatic Melanoma
Interventions: Drug: temozolomide;   Drug: ABT-888;   Drug: Placebo
2 Not yet recruiting Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Condition: Metastatic Melanoma
Intervention: Drug: Temozolomide, Decitabine, Panobinostat
3 Recruiting Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma
Condition: Melanoma
Interventions: Drug: temozolomide;   Drug: Sunitinib
4 Not yet recruiting Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Drug: sunitinib malate;   Drug: temozolomide
5 Recruiting Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
Conditions: Brain Neoplasms;   Melanoma
Interventions: Drug: Lomustine;   Drug: Temozolomide;   Drug: Thalidomide
6 Recruiting Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: Temozolomide;   Drug: Abraxane;   Drug: Cisplatin;   Biological: Interleukin-2;   Biological: Interferon alpha 2b
7 Recruiting Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: paclitaxel, carboplatin, temozolomide
8 Recruiting Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients
Condition: Melanoma
Interventions: Drug: Temozolomide (TMZ);   Drug: Pegylated Interferon Alpha-2b (PGI)
9 Recruiting Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Dietary Supplement: calcitriol;   Drug: temozolomide
10 Recruiting Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery
Condition: Melanoma (Skin)
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: temozolomide
11 Recruiting Abraxane and Temodar Plus Genasense in Advanced Melanoma
Condition: Melanoma
Interventions: Drug: Genasense® (oblimersen);   Drug: Abraxane® (paclitaxel protein-bound particles for injectable suspension);   Drug: Temodar® (temozolomide)
12 Recruiting Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: sorafenib tosylate;   Drug: temozolomide;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy
13 Recruiting Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma
Condition: Malignant Melanoma
Interventions: Drug: Decitabine;   Drug: Temozolomide;   Procedure: biopsy
14 Not yet recruiting Sodium Stibogluconate and Interferon Alfa-2b Followed By Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Advanced Melanoma or Other Cancer
Conditions: Brain and Central Nervous System Tumors;   Melanoma (Skin)
Interventions: Biological: recombinant interferon alfa-2b;   Drug: cisplatin;   Drug: sodium stibogluconate;   Drug: temozolomide;   Drug: vinblastine;   Genetic: gene expression analysis;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Recruiting PS-341 With Oral Temozolomide in Patients With Advanced Refractory Solid Tumors or Melanoma
Conditions: Solid Tumors;   Melanoma
Interventions: Drug: PS-341;   Drug: Temozolomide
16 Recruiting Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma
Conditions: Melanoma;   Skin Cancer
Intervention: Drug: Cisplatin, Vinblastine, Temozolomide
17 Recruiting A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: Allovectin-7®;   Drug: Dacarbazine (DTIC);   Drug: Temozolomide (TMZ)
18 Recruiting SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
Condition: Malignant Melanoma
Interventions: Biological: SentoClone®;   Drug: Temodal® or Dacarbazine Medac®
19 Recruiting Trial for Vaccine Therapy With Dendritic Cells - Transfected With hTERT-, Survivin- and Tumor Cell Derived mRNA + ex Vivo T Cell Expansion and Reinfusion in Patients With Metastatic Malignant Melanoma
Condition: Metastatic Malignant Melanoma
Interventions: Biological: Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion;   Drug: Temozolomide
20 Recruiting Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Condition: Malignant Melanoma
Interventions: Drug: Peginterferon alpha-2b, non- pegylated interferon alpha-2b;   Drug: Temozolomide, peginterferon alpha-2b

Previous Page Studies Shown (1-20) Next Page (21-22)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options